Carvedilol Tablets USP 6.25 mg
- Carvedilol Tablets USP 6.25 mg
Therapeutic Class: Cardiovascular Agents
Dosage Forms: Tablets
Brand Name: Carveria-6.25™
How it works?
Uses of Carvedilol Tablets USP 6.25 mg
- Chronic heart failure Indicated for mild to severe heart failure of ischemic or cardiomyopathic origin, usually alongside diuretics, ACE inhibitors, and digitalis. Helps improve survival and reduce hospitalizations.
- Post‑myocardial infarction therapy Used in clinically stable patients with left ventricular dysfunction (ejection fraction ≤40%) after a heart attack. Reduces cardiovascular mortality and prevents further complications.
- Hypertension management Effective in lowering blood pressure. Can be used alone or in combination with other antihypertensive agents, especially thiazide diuretics.
Precautions of Carvedilol Tablets USP 6.25 mg
- Chronic congestive heart failure → Administer only in addition to diuretics, ACE inhibitors, digitalis, and/or vasodilators. Therapy should begin only if the patient is stabilized on conventional therapy for at least 4 weeks. Monitor closely for hypotension, especially in elderly patients or those with low baseline blood pressure.
- Renal function in heart failure → Reversible deterioration of renal function may occur in patients with low blood pressure, ischemic heart disease, diffuse vascular disease, or renal insufficiency. Monitor renal function during dose titration. Reduce dose or discontinue if significant worsening occurs.
- Post‑myocardial infarction → Initiate therapy only in clinically stable patients who have received ACE inhibitors for at least 48 hours, with a stable dose for 24 hours.
- First‑degree AV block → Use with caution due to negative dromotropic effects.
- Chronic obstructive pulmonary disease (COPD) → Administer cautiously in patients with bronchospastic components, only if benefits outweigh risks.
- Diabetes mellitus → May mask hypoglycemia symptoms and worsen glucose control. Monitor blood sugar closely.
- Peripheral vascular disease → Beta‑blockers may aggravate arterial insufficiency.
- Raynaud’s phenomenon → May exacerbate peripheral circulatory symptoms.
- Thyrotoxicosis → Carvedilol may obscure symptoms.
- Anaesthesia & surgery → Exercise caution due to synergistic negative inotropic effects with anaesthetic drugs.
- Bradycardia → If pulse rate drops below 55 bpm, reduce dosage.
- Hypersensitivity → Beta‑blockers may increase sensitivity to allergens and severity of anaphylactic reactions.
- Severe skin reactions → Rare cases of TEN and SJS reported. Monitor for rash or skin changes.
- Psoriasis → Use only after careful risk‑benefit consideration.
- Metabolic acidosis → Administer with caution.
- Withdrawal syndrome → Do not discontinue abruptly. Taper gradually to avoid rebound angina or myocardial infarction.
Dosages administration of Carvedilol Tablets USP 6.25 mg
One tablet ones a day. The tablets do not need to be taken with a meal. However, it is recommended that heart failure patients take their carvedilol medication with food to allow the absorption to be slower and the risk of orthostatic hypotension to be reduced.
Side effects of Carvedilol Tablets USP 6.25 mg
Common Side Effects
- Respiratory infections → Bronchitis, pneumonia, upper respiratory tract infection.
- Urinary tract infection → May occur in some patients.
- Metabolic changes → Weight increase, hypercholesterolaemia, impaired blood glucose control (hyperglycaemia or hypoglycaemia) in patients with pre‑existing diabetes.
- Neurological effects → Dizziness, headache.
Uncommon Side Effects
- Cardiovascular symptoms → Presyncope (feeling faint), syncope (fainting).
- Neurological sensations → Paraesthesia (tingling or numbness).
- Eye effects → Visual impairment, decreased lacrimation (dry eye), eye irritation.
- Musculoskeletal pain → Pain in extremities.
Storage instruction of Carvedilol Tablets USP 6.25 mg
Store below 30°C temperature and protect from light.
Keep the medicine out of reach of children.
Packing details of Carvedilol Tablets USP 6.25 mg
Alu-PVC blister packs.
Carvedilol Tablets USP 6.25 mg is available in an Alu-PVC blister of 10 tablets. Such 03 blister with package insert in a carton.
interested? let’s talk.
Contact us directly to receive full information on the product, the formulation, the science behind it, stability data, and more. Our Business Development Manager is a click away.
Top GMP Certified Carvedilol Tablets USP 6.25 mg Manufacturer
Conical Pharmaceuticals, headquartered in Ahmedabad, India, is GMP‑certified manufacturer & exporter of Carvedilol Tablets USP 6.25 mg .We are delivering premium pharmaceutical and nutraceutical solutions worldwide. These tablets belong to the cardiovascular therapeutic class and are indicated for the management of hypertension, angina, and chronic heart failure.
With planned exports to Central Africa, Central America, and the CIS Region, and a strong distribution network across Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Cameroon, Chad, DRC, Equatorial Guinea, Gabon, and the Republic of the Congo, we ensure reliable supply and smooth market entry. Expansion into Nigeria, Ghana, Zambia, Zimbabwe, Kenya, the Philippines, Singapore, and Afghanistan further strengthens our global footprint.
Importers benefit from complete regulatory dossier support, including GMP Certification, COA,COPP. We also provide third‑party contract manufacturing, private labeling, and custom formulation options, empowering partners to launch their own brands with tailored solutions.
As a trusted contract manufacturer of cardiovascular care solutions, Conical Pharmaceuticals supplies to international importers, large distributors, pharmacy chains, and hospitals. With advanced R&D, flexible MOQ options, and consistent quality assurance, we enable partners to expand their market presence while delivering effective, high‑quality pharmaceutical solutions worldwide.
CUSTOM PACKAGING
Options available in size and style to meet your exact specifications and branding needs
SAMPLES AVAILABLE
Test before committing to bulk orders with complimentary samples for quality verification
LEAD TIME
45–60 days for timely delivery, ensuring reliable supply chain management
SHELF LIFE
Shelf Life: 24 months.
Frequently Asked Questions
Questions are useful tools, they open lines of communication; give us information; improve interactions, facilitate analysis, and many more.
-
Yes, Conical Pharmaceuticals is a GMP‑certified manufacturer in Ahmedabad, India, producing premium cardiovascular care formulations.
-
-
-
-
-
